share_log

Phibro Animal Health Analyst Ratings

Phibro Animal Health Analyst Ratings

Phibro 動物健康分析師評級
Benzinga ·  2023/09/01 11:49
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/01/2023 47.16% Roth MKM → $21 Reiterates Buy → Buy
08/31/2023 19.13% Morgan Stanley $18 → $17 Maintains Equal-Weight
08/29/2023 47.16% Roth MKM → $21 Reiterates Buy → Buy
07/27/2023 26.14% Morgan Stanley $18 → $18 Reiterates Equal-Weight → Equal-Weight
05/04/2023 26.14% Morgan Stanley $19 → $18 Maintains Equal-Weight
02/09/2023 33.15% Morgan Stanley $20 → $19 Maintains Equal-Weight
12/21/2022 26.14% Roth Capital → $18 Initiates Coverage On → Buy
11/10/2022 40.15% Morgan Stanley $21 → $20 Maintains Equal-Weight
09/16/2022 19.13% Barclays $22 → $17 Maintains Underweight
08/26/2022 47.16% Morgan Stanley $23 → $21 Maintains Equal-Weight
07/25/2022 54.17% Barclays → $22 Downgrades Equal-Weight → Underweight
01/10/2022 61.18% Barclays → $23 Upgrades Underweight → Equal-Weight
11/18/2021 61.18% Morgan Stanley → $23 Initiates Coverage On → Equal-Weight
07/07/2021 61.18% Barclays → $23 Downgrades Equal-Weight → Underweight
05/13/2021 54.17% Morgan Stanley $19 → $22 Maintains Underweight
05/08/2020 61.18% Credit Suisse $25 → $23 Maintains Neutral
02/06/2020 Gabelli & Co. Downgrades Buy → Hold
01/28/2020 61.18% Barclays → $23 Upgrades Underweight → Equal-Weight
09/05/2019 47.16% Morgan Stanley $30 → $21 Upgrades Underweight → Equal-Weight
08/29/2019 26.14% B of A Securities $29 → $18 Reiterates → Underperform
08/29/2019 26.14% Barclays $25 → $18 Maintains Underweight
08/28/2019 75.19% Credit Suisse $31 → $25 Reiterates → Neutral
06/11/2019 75.19% Barclays → $25 Initiates Coverage On → Underweight
05/09/2019 Gabelli & Co. Upgrades Hold → Buy
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
09/01/2023 47.16% 羅斯MKM →$21 重申 購買→購買
2023年08月31日 19.13% 摩根士丹利 $18→$17 維護 等重
2023年08月29日 47.16% 羅斯MKM →$21 重申 購買→購買
07/27/2023 26.14% 摩根士丹利 $18→$18 重申 等重→等重
05/04/2023 26.14% 摩根士丹利 $19→$18 維護 等重
02/09/2023 33.15% 摩根士丹利 $20→$19 維護 等重
2022年12月21日 26.14% 羅斯資本 →$18 開始承保 →購買
2022年11月10日 40.15% 摩根士丹利 $21→$20 維護 等重
09/16/2022 19.13% 巴克萊 $22→$17 維護 體重不足
2022年08月26日 47.16% 摩根士丹利 $23→$21 維護 等重
07/25/2022 54.17% 巴克萊 →$22 評級下調 等重→減碼
2022年1月10日 61.18% 巴克萊 →$23 升級 重量不足的→等重
2021年11月18日 61.18% 摩根士丹利 →$23 開始承保 →等重
07/07/2021 61.18% 巴克萊 →$23 評級下調 等重→減碼
2021/05/13 54.17% 摩根士丹利 $19→$22 維護 體重不足
05/08/2020 61.18% 瑞士信貸 $25→$23 維護 中性
02/06/2020 - 加貝利公司 評級下調 購買→Hold
1/28/2020 61.18% 巴克萊 →$23 升級 重量不足的→等重
2019年05月09日 47.16% 摩根士丹利 $30→$21 升級 重量不足的→等重
2019年08月29日 26.14% B of A證券 $29→$18 重申 →表現不佳
2019年08月29日 26.14% 巴克萊 $25→$18 維護 體重不足
2019年08月28日 75.19% 瑞士信貸 $31→$25 重申 →中性
2019年6月11日 75.19% 巴克萊 →$25 開始承保 →減持
2019年05月09日 - 加貝利公司 升級 持有→購買

What is the target price for Phibro Animal Health (PAHC)?

Phibro Animal Health(PAHC)的目標價格是多少?

The latest price target for Phibro Animal Health (NASDAQ: PAHC) was reported by Roth MKM on September 1, 2023. The analyst firm set a price target for $21.00 expecting PAHC to rise to within 12 months (a possible 47.16% upside). 9 analyst firms have reported ratings in the last year.

羅斯MKM於2023年9月1日報道了菲布羅動物健康公司(納斯達克:PAHC)的最新目標價。這家分析公司將目標價定為21.00美元,預計PAHC將在12個月內上漲至47.16%(可能上漲47.16%)。去年有9家分析公司公佈了評級。

What is the most recent analyst rating for Phibro Animal Health (PAHC)?

菲布羅動物健康(PAHC)的最新分析師評級是多少?

The latest analyst rating for Phibro Animal Health (NASDAQ: PAHC) was provided by Roth MKM, and Phibro Animal Health reiterated their buy rating.

菲布羅動物健康公司(納斯達克代碼:PAHC)的最新分析師評級由Roth MKM提供,菲布羅動物健康公司重申了他們的買入評級。

When is the next analyst rating going to be posted or updated for Phibro Animal Health (PAHC)?

菲布羅動物健康(PAHC)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phibro Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phibro Animal Health was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與菲布羅動物健康公司的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。菲布羅動物健康的上一次評級是在2023年9月1日提交的,所以你應該預計下一次評級將在2024年9月1日左右的某個時候公佈。

Is the Analyst Rating Phibro Animal Health (PAHC) correct?

分析師對Phibro Animal Health(PAHC)的評級正確嗎?

While ratings are subjective and will change, the latest Phibro Animal Health (PAHC) rating was a reiterated with a price target of $0.00 to $21.00. The current price Phibro Animal Health (PAHC) is trading at is $14.27, which is within the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但菲布羅動物健康(PAHC)的最新評級被重申,目標價在0.00美元至21.00美元之間。Phibro Animal Health(PAHC)目前的交易價格為14.27美元,在分析師的預測範圍內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論